Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
Choongho Lee, Won Jun Choi
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 99-116
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Two Years into the COVID-19 Pandemic: Lessons Learned
Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 9, pp. 1758-1814
Open Access | Times Cited: 103
Classic Signaling Pathways in Alveolar Injury and Repair Involved in Sepsis-Induced ALI/ARDS: New Research Progress and Prospect
Wenli Li, Duo Li, Yuansen Chen, et al.
Disease Markers (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 70
Relation of Serum Copper Status to Survival in COVID-19
Julian Hackler, Raban Heller, Qian Sun, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 1898-1898
Open Access | Times Cited: 79
A scoping review of the pathophysiology of COVID-19
Paul E. Marik, José Iglesias, Joseph Varón, et al.
International Journal of Immunopathology and Pharmacology (2021) Vol. 35
Open Access | Times Cited: 65
Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone
Olumayokun A. Olajide, Victoria U. Iwuanyanwu, Izabela Lepiarz‐Raba, et al.
Inflammation (2021) Vol. 44, Iss. 5, pp. 1865-1877
Open Access | Times Cited: 60
Blocking Egfr with Nimotuzumab: A Novel Strategy for Covid-19 Treatment
Henrry Diaz Londres, Jorge Jiménez Armada, Aray Hernández Martínez, et al.
Immunotherapy (2022) Vol. 14, Iss. 7, pp. 521-530
Open Access | Times Cited: 37
Noncoding RNAs in the COVID-19 Saga: An Untold Story
Mudasir Maqbool, Md Sadique Hussain, Nusrat K. Shaikh, et al.
Viral Immunology (2024) Vol. 37, Iss. 6, pp. 269-286
Closed Access | Times Cited: 9
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells
Lu Wang, Yun Li, Moyan Xu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 16, pp. 1635-1654
Open Access | Times Cited: 45
3D printed chitosan/polycaprolactone scaffold for lung tissue engineering: hope to be useful for COVID-19 studies
Farnoush Sadat Rezaei, Ayeh Khorshidian, Farzaneh Mahmoudi Beram, et al.
RSC Advances (2021) Vol. 11, Iss. 32, pp. 19508-19520
Open Access | Times Cited: 44
The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models
Scott Davies, Courtney J. Mycroft‐West, Isabel Pagani, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 40
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
Areez Shafqat, Shameel Shafqat, Sulaiman Al Salameh, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Update on transfusion-related acute lung injury: an overview of its pathogenesis and management
Yunhong Yu, Zhengqiu Lian
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
The impact of tocilizumab treatment on the severity of inflammation and survival rates in sepsis is significantly influence by the timing of administration
Taha Tavacı, Zekai Halıcı, Elif Çadırcı, et al.
Inflammopharmacology (2025)
Open Access
Understanding immune-modulatory efficacy in vitro
Somanjana Khatua, Jesús Simal‐Gándara, Krishnendu Acharya
Chemico-Biological Interactions (2021) Vol. 352, pp. 109776-109776
Open Access | Times Cited: 38
Zinc and Respiratory Viral Infections: Important Trace Element in Anti-viral Response and Immune Regulation
Fatemeh Sadeghsoltani, Iraj Mohammadzadeh, Mir-Meghdad Safari, et al.
Biological Trace Element Research (2021) Vol. 200, Iss. 6, pp. 2556-2571
Open Access | Times Cited: 37
Vaccine design and delivery approaches for COVID-19
Kiana Shahzamani, Fatemeh Mahmoudian, Shahrzad Ahangarzadeh, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108086-108086
Open Access | Times Cited: 34
A metabolic modeling approach reveals promising therapeutic targets and antiviral drugs to combat COVID-19
Fernando Santos‐Beneit, Vytautas Raškevičius, Vytenis Arvydas Skeberdis, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 33
The Inflammatory Cytokine Imbalance for Miscarriage, Pregnancy Loss and COVID-19 Pneumonia
Fortunato Vesce, Chiara Battisti, Michele Crudo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Molecular dynamics simulations of quinine encapsulation into biodegradable nanoparticles: A possible new strategy against Sars-CoV-2
Pierluigi Stipa, Stefania Marano, Roberta Galeazzi, et al.
European Polymer Journal (2021) Vol. 158, pp. 110685-110685
Open Access | Times Cited: 24
Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial
Amirreza Roostaei Firozabad, Zohreh Akhoundi Meybodi, Seyed Ruhollah Mousavinasab, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 21
The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic
Giuseppe Murdaca, Francesca Paladin, Alessandro Tonacci, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1688-1688
Open Access | Times Cited: 19
SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
Ali Salimi Jeda, Sina Abbassi, Atieh Mousavizadeh, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108232-108232
Open Access | Times Cited: 18
Relation of Serum Copper Status to Survival in COVID-19
Julian Hackler, Raban Heller, Qian Sun, et al.
(2021)
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top